Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden

https://doi.org/10.1016/S0960-8966(99)00055-3Get rights and content

Abstract

A retrospective epidemiological study of neuromuscular disorders was carried out in children born between 1979 and 1994 in western Sweden. The purpose was to determine overall and specific prevalences, overall cumulative incidence and birth incidences of selected disorders. Cases were ascertained from 12 different sources and medical records, investigations and diagnosis were reviewed. We found a point prevalence in the population <16 years of age of 63.1×10−5 for all neuromuscular disorders and 53.1×10−5 for inherited neuromuscular disorders. The point prevalence in children of school age was even higher. We found a higher occurrence of hereditary motor and sensory neuropathy, congenital myopathies and mitochondrial encephalo-myopathy, a slightly lower occurrence of Duchenne muscular dystrophy and spinal muscular atrophy and equal occurrence of myotonic dystrophy compared to previous studies in other countries. We conclude that neuromuscular disorders are more common in childhood than has previously been reported.

Introduction

Neuromuscular diseases constitute a complex group of heterogeneous, often inherited disorders. They can be broadly subdivided into disorders mainly affecting the anterior horn cell, peripheral nerve, neuromuscular junction and the muscle fibre. Some multisystem disorders such as myotonic dystrophy and mitochondrial myopathies are traditionally also included [1].

An epidemiological study is important not only for estimating various genetic parameters, e.g. gene frequencies, but also for monitoring the effects of any preventive measures such as genetic counselling, as well as for planning hospital resources, rehabilitation services and social welfare programmes for the handicapped in the community [2], [3]. It also gives valuable information for further research studies.

Population surveys that include all types of neuromuscular diseases are rare and few studies have addressed prevalences in childhood. Previous studies in the whole population have shown variable figures, with a point prevalence of 34.5×10− 5 in Northern Ireland [4] and 84.0×10−5 in Örebro County, Sweden [5], while the childhood prevalence has been estimated to be 24.9–42.0×10−5 [5], [6], [7].

Western Sweden has a homogeneous health care system with small migration of the population, thus offering unique possibilities of performing epidemiological studies on neurological disorders in childhood, as has been shown in previous studies [8], [9], [10], [11], [12]. The aims of the present study were to estimate overall and specific prevalences of neuromuscular disorders in childhood, and to estimate birth incidences and cumulative incidences of selected disorders with early onset and/or high childhood mortality.

Section snippets

Study population

The geographical area studied was the western Swedish health care region, with the city of Göteborg and the Counties of Halland, Bohuslän, Skaraborg and Älvsborg (Fig. 1). The area covers 28992.4 km2, constituting 7.1% of the total area of Sweden. Population figures were based on a national census. On the prevalence day (1st January 1995) the total population was 1 755 149 and the population <16 years of age was 359 676 (185 004 boys), i.e. 20% of the population in Sweden. The total school-age

Results

The search procedure and processes of exclusions and inclusions is given in Fig. 2. A total of 349 children with suspected neuromuscular disorders were identified and 78% of them were registered by at least two sources. Of these 94% had been examined by a paediatric neurologist. The exceptions were nine children with AIDP, eight children with polymyositis/dermatomyositis (who are traditionally followed by a paediatric rheumatologist), two children with Pompe's disease and one child each with

Discussion

We found a higher occurrence of neuromuscular disorders in children in western Sweden than has been reported in previous studies from other countries [6], [7]. High prevalence ratios have also been reported earlier from Sweden both in age-adjusted studies of children and in studies of the whole population [5], [10], [23], [24]. In the current study, the cumulative incidence exceeds the prevalence ratio. This probably reflects the high childhood mortality of some of these disorders.

Variations

Acknowledgements

The authors are grateful to the following persons: from Sahlgrenska University Hospital, M. Kyllerman and G. Hagberg, Department of Paediatrics; A. Oldfors, Department of Pathology; J. Wahlström, Department of Clinical Genetics; G. Wallin, Department of Clinical Neurophysiology. From the regional child rehabilitation centre: A. Lundberg. From Linköping University Hospital: K.G. Henriksson, Departments of Pathology and Neurophysiology. From the local child rehabilitation centres; I. Olsson in

References (38)

  • S.E. Tangsrud et al.

    Child neuromuscular disease in southern Norway

    Prevalence, age and distribution of diagnosis with special reference to ‘non-Duchenne muscular dystrophy‘. Clin Genet

    (1988)
  • B. Hagberg et al.

    The changing panorama of cerebral palsy in Sweden

    VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr

    (1996)
  • E. Fernell et al.

    Epidemiology of infantile hydrocephalus in Sweden

    I. Birth prevalence and general data. Acta Paediatr Scand

    (1986)
  • B. Hagberg et al.

    Hereditary motor and sensory neuropathies in Swedish children

    I. Prevalence and distribution by disability groups. Acta Paediatr Scand

    (1983)
  • P. Uvebrant et al.

    The epidemiology of progressive encephalopathies in childhood

    I. Live birth prevalence in west Sweden. Neuropediatrics

    (1992)
  • A.E.H. Emery

    Diagnostic criteria for neuromuscular disorders

    (1997)
  • P.J. Dyck et al.

    Peripheral Neuropathy

    (1993)
  • A.K. Asbury et al.

    Criteria for diagnosis of Guillain-Barré syndrome

    Ann Neurol

    (1978)
  • D.R. Cornblath et al.

    Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)

    Neurology

    (1991)
  • Cited by (0)

    View full text